Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIAsp 30 extension in young T1DM
NCT01486381Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2002
- Primary completion
- May 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of biphasic insulin aspart in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Primary endpoints: Number of hypoglycaemic episodes, Occurence of adverse events and 1 more. Started Mar 2002; status: completed.
02
Drugs
biphasic insulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01486381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01486381.